Search Login Register

Riluzole Summary

Description: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Also Known As: 2-Amino-6-trifluoromethoxybenzothiazole; Aventis Behring Brand of Riluzole; Aventis Brand of Riluzole; Impax Brand of Riluzole; PK-26124 Show All >>

Networked: 464 relevant articles (48 outcomes, 124 trials/studies) for this Drug

Key Diseases for which Riluzole is Relevant

  1. Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) : 14 outcomes 34 studies in 174 results
  2. Melanoma (Melanoma, Malignant) : 3 outcomes 7 studies in 14 results
  3. Disease Progression : 3 outcomes 6 studies in 25 results
  4. Spinal Cord Injuries (Spinal Cord Injury) : 3 outcomes 6 studies in 25 results
  5. Ischemia : 3 outcomes 2 studies in 20 results
Show All >>

Drugs Related to Riluzole

  1. Glutamic Acid (Glutamate)
  2. N-Methylaspartate (NMDA)
  3. Riluzole
  4. Harmaline
  5. Ketamine
  6. Sodium Channels (Sodium Channel)
  7. Lithium
  8. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
  9. Memantine (Namenda)
  10. Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
Show All >>

Therapies Related to Riluzole

  1. Heterologous Transplantation (Xenotransplantation)
  2. Tracheostomy
  3. Drug Therapy (Chemotherapy)
  4. Intraperitoneal Injections
  5. Radiotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.